--- title: Deep Genomics slug: deep-genomics-4153a url: /detay/deep-genomics-4153a type: article language: English entity: primary: Deep Genomics type: article categories: - name: Science And Technology slug: bilim url: /kategori/bilim - name: Engineering slug: muhendislik url: /kategori/muhendislik - name: Technology And Innovation slug: teknoloji url: /kategori/teknoloji tags: - Deep Genomics author: Ömer Said Aydın created_at: 2025-10-25T15:27:42.985322+03:00 updated_at: 2025-11-12T16:47:19.042267+03:00 image: https://cdn.t3pedia.org/media/uploads/2025/10/25/0ZMhqUfprpDRFD83MLnh48D1Jl7bRbpZ.webp --- # Deep Genomics ## KURE Information Cards ![7OVp7rmtBzGpcx6yhOsf0ZIvxSCWhPU1.webp](https://cdn.t3pedia.org/media/uploads/2025/10/25/q9TdMSD377p6Ly5YTzCKADI4reu9XLfi.webp) *Deep Genomics* | Field | Value | |-------|-------| | Website(s) | https://www.deepgenomics.com | | Founded(Text) | 2015 | | Founder(s) | Brendan Frey | | Domain of Activity | AI-enabled genetic therapy development | | Core Technology | BigRNA, the first foundational AI model developed for RNA biology | | Headquarters | Toronto, Ontario, Canada | ## Article Content **Deep Genomics** is a biotechnology company specializing in [artificial intelligence](/en/detay/machine-learning-a2c4b/llms.txt)–driven [genetic](/en/detay/genetic-engineering-94edd/llms.txt) therapy development. Headquartered in **Toronto, Ontario, Canada**, with an additional office in **Boston, Massachusetts**, the company operates on the principle that the future of medical innovation lies in artificial intelligence, given the inherent complexity of biological systems. [Deep Genomics](/en/detay/deep-genomics-cba18/llms.txt) develops AI-based biological models to identify and treat genetic disorders. ### **Scientific Approach and Research Focus** Deep Genomics aims to decode the molecular mechanisms underlying genetic diseases by analyzing **RNA biology** through an AI-powered research platform. Its studies focus on programming [RNA](/en/detay/rna-ribonucleic-acid-0be42/llms.txt) as a therapeutic tool and identifying molecular targets for genetic conditions. The company’s systems evaluate RNA biology data to assess genetic variants and determine the most promising therapeutic candidates. ### **AI Platform and BigRNA Model** The company’s core technological infrastructure consists of large-scale datasets, data processing pipelines, machine learning systems (including **foundation models** and **large language models**), and software engineering frameworks. Designed for biological accuracy, this AI platform models genetic interactions with high resolution. In **2018**, the platform identified splicing errors in RNA and proposed the first therapeutic targets for their correction. In **2023**, Deep Genomics released **BigRNA**, the world’s first foundation model for RNA biology—an AI system capable of predicting RNA expression at sub-gene resolution. BigRNA performs multiple functions, including: - Genetic target identification - Prediction of molecule–target interactions - Therapeutic candidate design - Development of surrogate molecules for *in vivo* testing Its successor, **BigRNA+**, is designed to enable the exploration of new biological mechanisms and genetic variants associated with more complex hereditary diseases. ### **Publications and Scientific Contributions** Researchers at Deep Genomics have published extensively on RNA biology, genetic variant interpretation, and [deep learning](/en/detay/deep-neural-networks-23d64/llms.txt) applications in genomics. Their studies have appeared in journals such as *Nature Biotechnology*, *Science*, *NPJ Genomic Medicine*, *Frontiers in Molecular Biosciences*, and *Nucleic Acid Therapeutics*. One of the company’s landmark papers, **“The Human Splicing Code Reveals New Insights into the Genetic Determinants of Disease”** (2015), represented one of the earliest comprehensive applications of deep learning to gene regulation and disease association. ### **Leadership and Expertise** The leadership team includes **Brendan Frey** (Founder and Chief Innovation Officer), **Brian O’Callaghan** (Chief Executive Officer), and **Greg Hoffman** (Chief Scientific Officer). Deep Genomics employs over **100 professionals** specializing in AI, molecular biology, organic chemistry, clinical development, *in vitro* disease modeling, automation, and software engineering. Advisors to the company include prominent figures such as **Yann LeCun**, **Masad Damha**, **Jennifer Cook**, and **Benjamin Neale**, who contribute expertise across AI research, molecular therapeutics, and computational genomics. ### **Location and Research Ecosystem** Deep Genomics’ headquarters are located in the **MaRS Discovery District** in Toronto, surrounded by major academic and research institutions, including the **University of Toronto**, **research hospitals**, and the **Vector Institute for Artificial Intelligence**. This positioning provides a strategic advantage for fostering collaborations between academia and industry. ### **Financial and Corporate Structure** Deep Genomics is backed by global investment funds such as **SBIA**, **Fidelity**, **CPP Investments**, **Khosla Ventures**, and **True Ventures**. Its board of directors includes members with backgrounds spanning academia, biotechnology, and venture capital. ### **Scientific Vision** Deep Genomics envisions a future where **RNA therapeutics** can provide practical treatments for “every gene and every genetic condition.” Leveraging scalable AI-driven discovery platforms, the company seeks to accelerate the identification of novel genetic targets and the development of precision therapies for complex and rare diseases. ## Academic Sources and References 1. Deep Genomics. “AI Platform.” Official Website. Accessed October 24, 2025. https://www.deepgenomics.com/AI-Platform/.Deep Genomics. “Company.” Official Website. Accessed October 24, 2025. https://www.deepgenomics.com/company/.Deep Genomics. “Home.” Official Website. Accessed October 24, 2025. https://www.deepgenomics.com/.Deep Genomics. “About.” LinkedIn. Accessed October 24, 2025. https://www.linkedin.com/company/deep-genomics/?originalSubdomain=ca.